4/19/23-Collaborative Care: Addressing SUD Related Mental Health Co-Morbidities

Presentation Resources

• Abrahamsson T, Berge J, Ojehagen A, et al. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-–a nation-wide register-based open cohort study. Drug Alcohol Depend 2017;
  https://www.researchgate.net/publication/314132121_Benzodiazepine_z-drug_and_pregabalin_prescriptions_and_mortality_among_patients_in_opioid_maintenance_treatment-A_nation-wide_register-based_open_cohort_study/link/58dc1c19458515152b3d2a2e/download

• Chan YY, Chen YH, Yang SN, et al. Clinical efficacy of traditional Chinese medicine, suan zao ren tang, for sleep disturbance during methadone maintenance: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med 2015; 2015
  . Epub 2015 Aug 4
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539464/

• Dreifuss JA, Griffin ML, Frost K, et al. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: results from a multisite study. Drug Alcohol Dep 2013;131:112-118
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638044/

• Farney RJ, McDonald AM, Boyle KM, et al. Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone. Eur Respir J 2013;42:394-403
  https://erj.ersjournals.com/content/42/2/394.long

• Fava M, Memisoglu A, Thase ME, et al. Opioid modulation with buprenorphine/samidorphanas adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial. Am J Psychiatry 2016;173:499-508
  https://www.semanticscholar.org/paper/Opioid-Modulation-With-Buprenorphine%2FSamidorphan-as-Fava-Memisoglu/5dbf66d0a1f277dd7d321f20b636e5609fb85104

• Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2004;65:948-958
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676679/

• Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Jama Psychiatry 2016;73(1):39-47
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062605/

• Grella CE, Karno MP, Warda US, et al. Gender and comorbidity among individuals with opioid use disorders in the NESARC study
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708101/

• Hedges DW, Brown BL, Shwalb DA, et al. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials. J Psychopharmacol 2007;21:102-111
  https://journals.sagepub.com/doi/abs/10.1177/0269881106065102

• Huhn M, Tardy M, Spineli LM, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic review and meta-analysis. JAMA Psychiatry 2014;71:706-715
  https://slatestarcodex.com/blog_images/forestplotpaper.pdf

• Krupitsky E, Zvartau E, Blokhina E, et al. Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant. Am J Drug Alcohol Abuse 2016;42:614-620
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156574/

• Li Y, Liu XB, Zhang Y. Acupuncture therapy for the improvement of sleep quality of outpatients receiving methadone maintenance treatment: a randomized controlled trial. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012;32:1056-1069

• Martins SS, Keyes KM, Storr CL, et al. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Dep 2009;103:16-24
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699563/

• Mills KL, Lynskey M, Teesson M, et al. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Dep 2005;77:243-249

• Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry 2004;56:793-802

• Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015;350: h2698. doi: 10.1136/bmj.h2698
  https://www.bmj.com/content/350/bmj.h2698

• Peirce JM, Brooner RK, King VL, et al. Effect of traumatic event re-exposure and PTSD on substance abuse disorder treatment response. Drug Alcohol Depend 2016;158:126-131
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698104/

• Robabeh S, Jafar MM, Sharareh H, et al. The effect of cognitive behavior therapy in insomnia due to methadone maintenenace therapy: a randomized clinical trial. Iran J Med Sci 2015;5:396-403
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567598/

• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-tern outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917
  https://ajp.psychiatryonline.org/doi/full/10.1176/ajp.2006.163.11.1905?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&

• Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2017;13:307-380
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263087

• Saunders EC, McGovern MP, Lambert-Harris C, et al. The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders. Am J Addict 2015;24:722-731
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866634/

• Schiff M, Nacasch N, Levit S, et al. Prolonged exposure for treating PTSD among female methadone patients who were survivors of sexual abuse in Israel. Soc Work Health Care 2015;54:687-707

• Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4:487-504
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2576317/

• Seal KH, Maguen SH, Bertenthal D, et al. Observational evidence for buprenorphine’s impact on posttraumatic stress symptoms in veterans with chronic pain and opioid use disorder. J Clin Psychiatry 2016;77:1182-1188

• Seyffert M, Lagisetty P, Landgraf J, et al. Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One 2016; 11(2):e0149139. doi: 10.1371/journal.pone.0149139
  https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0149139&type=printable

• Smith MT, Perlis ML, Park BS, et al. Comparative meta-analysis pf pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2—2;159:5-11
  https://www.researchgate.net/publication/11584627_Comparative_Meta-Analysis_of_Pharmacotherapy_and_Behavior_Therapy_for_Persistent_Insomnia

• Tang NKY, Lereya ST, Boulton H, et al. Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta- analysis of patient-reported outcomes in randomized controlled trials. Sleep 2-15;38:1751-1764
  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813361/

• Winkler A, Auer C, Doering BK, et al. Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 2014;28:799-816
  https://www.researchgate.net/publication/265175567_Drug_Treatment_of_Primary_Insomnia_A_Meta-Analysis_of_Polysomnographic_Randomized_Controlled_Trials

• Wu JQ, Appleman ER, Salazar RD, et al. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta- analysis. JAMA Intern Med 2015;175:1461-1472
  https://www.researchgate.net/publication/279807824_Cognitive_Behavioral_Therapy_for_Insomnia_Comorbid_With_Psychiatric_and_Medical_Conditions_A_Meta-analysis

• Hasin 2015